Gene Therapy Market Size, Share, Trend, Forecast, & Industry Analysis

1
Presents a Research Report on
Gene Therapy Market
The Gene Therapy Market is Segmented by Vector
Type (Non-Viral Vectors, Viral Vectors ), by
Indication Type (Neurological Diseases, Cancer,
Hepatological Diseases, Duchenne Muscular
Dystrophy, and Others), by Delivery Method Type
(In Vivo Gene Therapy, Ex Vivo Gene Therapy), and
by Region (North America, Europe, Asia-Pacific,
and Rest of the World).


www.stratviewresearch.com
Market Reports
Advisory Consulting
Sourcing Intelligence
2
Gene Therapy Market Growth and Forecast
Highlights Drivers

• Gene Therapy Market is likely to witness an
  impressive CAGR of 27.8 during the forecast
  period.
• The prime factors contributing to the growth of
  the market are rising incidences of cancer, and
  other chronic diseases, availability of
  reimbursements, and increasing approvals and
  launches of new products.
• Gene therapy is a technique which uses the
  introduction of DNA into a patients body in
  order to treat or prevent a disease.
• A functioning gene is present in the introduced
  DNA, to correct the effects of a disease, which
  causes mutations.
• This therapy aims at reestablishing normal
  function and involves repairing, repressing, or
  replacing dysfunctional genes that cause disease.
  
• Gene therapy
• Serves as a promising treatment option for some
  genetic diseases such as muscular dystrophy and
  cystic fibrosis, certain inherited disorders,
  cancer, and viral infections.
• Addresses the root cause of severe diseases by
  aiding in drug development to identify the right
  target and approach.
• Provides a path to produce the functional protein
  in case of certain disorders where known genetic
  mutations lead to deficient or nonfunctional
  protein production by fixing the underlying
  defect.
• Poses a relatively low risk as a new gene
  introduced will integrate itself into the genome
  of the patient and continue functioning without
  hampering the operations of other genes.

3
Market Insights

• By Indication Type
• The market is segmented as neurological diseases,
  cancer, duchenne muscular dystrophy,
  heptological, and others.
• The cancer segment is expected to experience the
  highest growth in the market during the forecast
  period.
• This growth can be attributed to the approval of
  a growing number of gene therapies for the
  treatment of cancer and the rising incidences of
  hematologic cancers.
• By Vector Type
• The market is segmented as non-viral and viral
  vectors.
• The non-viral vectors segment has been further
  bifurcated into oligonucleotides and others and
  the viral vectors segment has been further
  bifurcated into retroviral vectors,
  adeno-associated virus vectors, and others.
• The non-viral vectors segment is expected to
  grow at a higher rate over the forecast period,
  owing to the higher market penetration of
  oligonucleotide-based non-viral vector gene
  therapies.
• By Region
• In terms of regions, North America is estimated
  to be the largest market during the forecast
  period with lucrative growth opportunities.
• This growth can be attributed to the presence of
  major players, rising prevalence of chronic
  diseases, high and increasing healthcare
  expenditure, presence of advanced healthcare
  infrastructure, and availability of
  reimbursements.
• Europe and Asia-Pacific are also expected to
  offer substantial growth opportunities during the
  forecast period.

4
Competitive Insights
Gene Therapy Market, regional expansion, and
execution of mergers acquisitions are the key
strategies adopted by the major players to gain a
competitive edge in the market. Key Companies
Analysed

• Biogen, Inc.
• Novartis International AG
• Gilead Sciences, Inc.
• Spark Therapeutics, Inc.
• MolMed S.p.A.
• Orchard Therapeutics plc.
• Sibiono GeneTech Co. Ltd.
• Shanghai Sunway Biotech Co., Ltd.
• Bluebird Bio
• Human Stem Cells Institute PJSC
• AnGes MG, Inc.
• Alnylam Pharmaceuticals, Inc.
• Sarepta Therapeutics, Inc.
• Jazz Pharmaceuticals, Inc.
• Akcea Therapeutics
• Dynavax Technologies Corporation.

5
Research Methodology
Data Analysis Top Down and Bottom Up Approach)
Data Triangulation Data Evaluation and Multiple
Data Triangulation)
Final Deliverables Final Report with All Findings)
Stratview Research follows a rigorous methodology
with high emphasis on primary research and
multiple ways of data triangulation. We conduct
primary research across the value chain to
provide 360 degree view of the market.
Secondary Research
Stratview Research Internal Knowledgebase
Primary Research

• Annual Reports / Fact Book
• Company Websites
• Magazines / Publications
• Press Releases Journals
• Industry News
• Association Articles
• Government Documents
• Social Media
• Others

• Robust database across value chain
• In-house industry veterans as advisors
• Project based subject matter experts

• Industry Players
• Industry Experts
• Suppliers
• Customers
• Associations
• Government Institutions
• Others

6
Report Features

• This report provides market intelligence in the
  most comprehensive way. The report structure has
  been kept such that it offers maximum business
  value. It provides critical insights on the
  market dynamics and will enable strategic
  decision making for the existing market players
  as well as those willing to enter the market. The
  following are the key features of the report
• Market structure Overview, industry life cycle
  analysis, supply chain analysis.
• Market environment analysis Growth drivers and
  constraints, Porters five forces analysis, SWOT
  analysis.
• Market trend and forecast analysis.
• Market segment trend and forecast.
• Competitive landscape and dynamics Market share,
  product portfolio, product launches, etc.
• Attractive market segments and associated growth
  opportunities.
• Emerging trends.
• Strategic growth opportunities for the existing
  and new players.
• Key success factors.

7
Market Segmentation

• The gene therapy market is segmented into the
  following categories.
• Gene Therapy Market Size, Share, Forecast, by
  Vector Type
• Non-Viral Vectors
• (Regional Analysis North America, Europe,
  Asia-Pacific, and RoW)
• (Vector Type Analysis Oligonucleotides and Other
  Non-Viral Vectors)
• Viral Vectors
• (Regional Analysis North America, Europe,
  Asia-Pacific, and RoW)
• (Vector Type Analysis Retroviral Vectors,
  Adeno-Associated Virus Vectors, and Other Viral
  Vectors)
• Gene Therapy Market Size, Share, Forecast, by
  Indication Type
• Neurological Diseases (Regional Analysis North
  America, Europe, Asia-Pacific, and RoW)
• Cancer (Regional Analysis North America, Europe,
  Asia-Pacific, and RoW)
• Duchenne Muscular Dystrophy (Regional Analysis
  North America, Europe, Asia-Pacific, and RoW)
• Hepatological Diseases (Regional Analysis North
  America, Europe, Asia-Pacific, and RoW)
• Others (Regional Analysis North America, Europe,
  Asia-Pacific, and RoW)

8
Market Segmentation

• Gene Therapy Market Size, Share, Forecast, by
  Delivery Method Type
• In Vivo Gene Therapy (Regional Analysis North
  America, Europe, Asia-Pacific, and RoW)
• Ex Vivo Gene Therapy (Regional Analysis North
  America, Europe, Asia-Pacific, and RoW)
• Gene Therapy Market Size, Share, Forecast, by
  Region
• North America (Country Analysis the USA, Canada,
  and Mexico)
• Europe (Country Analysis Germany, France, the
  UK, Russia, Spain, and Rest of Europe)
• Asia-Pacific (Country Analysis China, Japan,
  India, South Korea, and Rest of Asia-Pacific)
• Rest of the World (Sub-Region Analysis Latin
  America, the Middle East, and Others)

9
About Stratview Research
Stratview Research is a global market
intelligence firm providing high quality
syndicated reports, custom research and
consulting services.
Our Services
Why Us?
High Customer Delight
Rich Industry Experience
Robust Methodology
Effective Business Decisions
10
Contact Us for More Information and Sample Pages
Ask for Sample Pages here https//www.stratviewr
esearch.com/Request-Sample/942/gene-therapy-market
.htmlform
11
Thank You